AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Nexalin Technology Names Justin Van Fleet as CFO
ByAinvest
Friday, Aug 1, 2025 9:04 am ET1min read
Nexalin Technology has appointed Justin Van Fleet as CFO, effective August 1, 2025. Van Fleet brings over 20 years of experience in public accounting and assurance services, most recently serving as Partner at Marcum LLP. This appointment is seen as a strategic move to strengthen Nexalin Technology's financial management and guidance.
Nexalin Technology, Inc. (NXL), a leader in Deep Intracranial Frequency Stimulation (DIFS™), has appointed Justin Van Fleet as Chief Financial Officer, effective August 1, 2025. Van Fleet brings over 20 years of experience in public accounting and assurance services, most recently serving as Partner at Marcum LLP [1].The appointment comes at a crucial time as Nexalin advances its Generation 2 and Generation 3 devices through FDA review. These non-invasive neurostimulation systems are designed to treat anxiety, depression, and other mental health conditions without drugs or surgery [2]. Van Fleet will oversee the company's financial strategy, planning, and reporting functions during this critical growth phase [3].
Van Fleet's extensive background in public accounting and regulatory compliance is expected to be crucial as Nexalin continues to advance its innovative neurostimulation devices. He has a strong track record of developing robust financial systems, mentoring high-performing teams, and ensuring compliance with the highest professional and regulatory standards [4].
The appointment of Van Fleet is seen as a strategic move to strengthen Nexalin Technology's financial management and guidance. His expertise is expected to be instrumental in scaling the company's operations and expanding its neurostimulation platform [3].
Nexalin's CEO, Mark White, expressed enthusiasm for the new appointment, stating that Van Fleet's proficiency in public accounting and regulatory compliance will be invaluable as the company scales its operations and continues advancing its groundbreaking neurostimulation platform [4].
References:
[1] https://www.nasdaq.com/articles/nexalin-technology-appoints-justin-van-fleet-cfo
[2] https://seekingalpha.com/news/4476548-nexalin-technology-appoints-justin-van-fleet-as-cfo
[3] https://www.gurufocus.com/news/3026859/nexalin-technology-appoints-highly-experienced-financial-leader-justin-van-fleet-as-cfo-to-support-nexalins-next-phase-of-growth-and-strategic-initiatives-nxl-stock-news
[4] https://www.stocktitan.net/news/NXL/nexalin-technology-appoints-highly-experienced-financial-leader-o9rom07bo6x2.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet